Nath Bio-Genes (India) Limited announced that at its board meeting held on April 22, 2023, the Board of Directors has recommended dividend for financial year 2022-23 of INR 2 (that is 20%) per equity shares of the nominal value of INR 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company.